Terms: = Endocrine gland cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Treatment
47 results:
1. African American vs Caucasian race/ethnicity in adrenocortical carcinoma patients.
Panunzio A; Tappero S; Hohenhorst L; Cano Garcia C; Piccinelli M; Barletta F; Tian Z; Tafuri A; Briganti A; De Cobelli O; Chun FKH; Tilki D; Terrone C; Saad F; Shariat SF; Bourdeau I; Cerruto MA; Antonelli A; Karakiewicz PI
Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37043366
[TBL] [Abstract] [Full Text] [Related]
2. Spatial-Temporal Trends in Ovarian cancer Outcomes in California.
Villanueva C; Chang J; Ziogas A; Bristow RE; Vieira VM
JNCI Cancer Spectr; 2022 Nov; 6(6):. PubMed ID: 36238987
[TBL] [Abstract] [Full Text] [Related]
3. CT imaging phenotypes linked to CA125 and HE4 biomarkers are highly predictive in discriminating between hereditary and sporadic ovarian cancer patients.
Manganaro L; Celli V; Viggiani V; Berardelli E; Granato T; Tartaglione S; Farina A; Catalano C; Angeloni A; Anastasi E
Tumour Biol; 2022; 44(1):171-185. PubMed ID: 36093649
[TBL] [Abstract] [Full Text] [Related]
4. Intraductal Papillary Mucinous Neoplasm Arising from Heterotopic Pancreas in Stomach: A Case Report and Review of Literature.
Pang Y; Liu Y; Liu Q; Hou G
Int J Surg Pathol; 2023 Aug; 31(5):708-713. PubMed ID: 35946106
[TBL] [Abstract] [Full Text] [Related]
5. Predictors of survival rate in patients with pancreatic cancer: A multi-center analytical study in Iran.
Bahardoust M; Abyazi MA; Emami SA; Ghadimi P; Khodabandeh M; Mahmoudi F; Hosseinzadeh R; Heiat M; Agah S
Cancer Rep (Hoboken); 2022 Aug; 5(8):e1547. PubMed ID: 34494396
[TBL] [Abstract] [Full Text] [Related]
6. A UK based two-centre review of multifocality and its role in the treatment of papillary thyroid cancer.
Li LQ; Hey SY; Andreeva D; Tornari C; Sawant R; Harding NE; Adamson R; Hay A; Simo R; Nixon IJ
Eur J Surg Oncol; 2022 Jan; 48(1):14-20. PubMed ID: 34253424
[TBL] [Abstract] [Full Text] [Related]
7. Pharmacoeconomic Evaluation of Erlotinib for the treatment of Pancreatic cancer.
Bao K; Li X; He X; Jian L
Clin Ther; 2021 Jun; 43(6):1107-1115. PubMed ID: 34059328
[TBL] [Abstract] [Full Text] [Related]
8. Predictive factors of radioiodine therapy failure in Graves' Disease: A meta-analysis.
Shalaby M; Hadedeya D; Toraih EA; Razavi MA; Lee GS; Hussein MH; Weidenhaft MC; Serou MJ; Ibraheem K; Abdelgawad M; Kandil E
Am J Surg; 2022 Feb; 223(2):287-296. PubMed ID: 33865565
[TBL] [Abstract] [Full Text] [Related]
9. Disparities in Stage-Specific Guideline-Concordant cancer-Directed treatment for Patients with Pancreatic Adenocarcinoma.
Hamad A; DePuccio M; Reames BN; Dave A; Kurien N; Cloyd JM; Shen C; Pawlik TM; Tsung A; McAlearney AS; Ejaz A
J Gastrointest Surg; 2021 Nov; 25(11):2889-2901. PubMed ID: 33768427
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic Lobectomy for Bethesda III Thyroid Nodules: Pathological Outcomes and Risk Factors for Malignancy.
Walters BK; Garrett SL; Aden JK; Williams GM; Butler-Garcia SL; Newberry TR; Mckinlay AJ
Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):1064-1068. PubMed ID: 33567896
[TBL] [Abstract] [Full Text] [Related]
11. Mucinous cystic neoplasms of the pancreas in the modern era. Experience with 707 patients.
Ahmad M; Maegawa FB; De La Rosa E; Davis B; Tyroch A; Konstantinidis IT
Am J Surg; 2020 Dec; 220(6):1433-1437. PubMed ID: 32938530
[TBL] [Abstract] [Full Text] [Related]
12. Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer.
Chen C; Xu Y; Huang X; Mao F; Shen S; Xu Y; Sun Q
Medicine (Baltimore); 2020 Aug; 99(32):e21560. PubMed ID: 32769897
[TBL] [Abstract] [Full Text] [Related]
13. Controversial Role of Adjuvant Therapy in Node-Negative Invasive Intraductal Papillary Mucinous Neoplasm.
Mungo B; Croce C; Oba A; Ahrendt S; Gleisner A; Friedman C; Schulick RD; Del Chiaro M
Ann Surg Oncol; 2021 Mar; 28(3):1533-1542. PubMed ID: 32743713
[TBL] [Abstract] [Full Text] [Related]
14. The safety and efficacy of endoscopic ultrasound-guided ablation therapy for solid pancreatic tumors: a systematic review.
Zhang L; Tan S; Huang S; Zhong C; Lü M; Peng Y; Tang X
Scand J Gastroenterol; 2020 Sep; 55(9):1121-1131. PubMed ID: 32730715
[TBL] [Abstract] [Full Text] [Related]
15. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.
Van Cutsem E; Tempero MA; Sigal D; Oh DY; Fazio N; Macarulla T; Hitre E; Hammel P; Hendifar AE; Bates SE; Li CP; Hingorani SR; de la Fouchardiere C; Kasi A; Heinemann V; Maraveyas A; Bahary N; Layos L; Sahai V; Zheng L; Lacy J; Park JO; Portales F; Oberstein P; Wu W; Chondros D; Bullock AJ;
J Clin Oncol; 2020 Sep; 38(27):3185-3194. PubMed ID: 32706635
[TBL] [Abstract] [Full Text] [Related]
16. Effects of miR-492 on migration, invasion, EMT and prognosis in ovarian cancer by targeting SOX7.
Wang Z; Liu Y; Wang M; Zhao J
J BUON; 2020; 25(2):797-804. PubMed ID: 32521870
[TBL] [Abstract] [Full Text] [Related]
17. Pulmonary and overall healthcare utilization after childhood and young adult thyroid cancer.
Di Giuseppe G; Zuk AM; Wasserman JD; Pole JD
Endocr Relat Cancer; 2020 Jun; 27(6):391-402. PubMed ID: 32252026
[TBL] [Abstract] [Full Text] [Related]
18. treatment patterns and outcomes in pancreatic cancer: Retrospective claims analysis.
Doleh Y; Lal LS; Blauer-Petersen C; Antico G; Pishvaian M
Cancer Med; 2020 May; 9(10):3463-3476. PubMed ID: 32212262
[TBL] [Abstract] [Full Text] [Related]
19. Nodal downstaging as a treatment goal for node-positive pancreatic cancer.
Portuondo JI; Massarweh NN; Zhang Q; Chai CY; Tran Cao HS
Surgery; 2019 Jun; 165(6):1144-1150. PubMed ID: 30745009
[TBL] [Abstract] [Full Text] [Related]
20. [A retrospective study of tumor and fertility outcomes after fertility-sparing surgical treatment of patients with borderline ovarian tumors].
Liu F; Hu DH; Zhang YF; Wang B; Huang K; Wang CY; Xia XY
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3699-3703. PubMed ID: 29325322
[No Abstract] [Full Text] [Related]
[Next]